Infrared fluorescent imaging as a potent tool for in vitro, ex vivo and in vivo models of visceral leishmaniasis.

Infrared fluorescent imaging as a potent tool for in vitro, ex vivo and in vivo models of visceral leishmaniasis.

BACKGROUND:Visceral leishmaniasis (VL) is hypoendemic in the Mediterranean region, where it is caused by the protozoan Leishmania infantum. An effective vaccine for humans is not yet available and the severe side-effects of the drugs in clinical use, linked to the parenteral administration route of...

Full description

Bibliographic Details
Main Authors:	Estefanía Calvo-Álvarez, Kostantinos Stamatakis, Carmen Punzón, Raquel Álvarez-Velilla, Ana Tejería, José Miguel Escudero-Martínez, Yolanda Pérez-Pertejo, Manuel Fresno, Rafael Balaña-Fouce, Rosa M Reguera
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-03-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4380447?pdf=render

Similar Items

A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery.
by: Raquel Álvarez-Velilla, et al.
Published: (2019-02-01)

Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis.
by: Estefania Calvo-Álvarez, et al.
Published: (2012-01-01)

Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of <i>Leishmania donovani</i> Visceral Leishmaniasis
by: Estela Melcon-Fernandez, et al.
Published: (2023-01-01)

First evidence of intraclonal genetic exchange in trypanosomatids using two Leishmania infantum fluorescent transgenic clones.
by: Estefanía Calvo-Álvarez, et al.
Published: (2014-09-01)

Correction: First Evidence of Intraclonal Genetic Exchange in Trypanosomatids Using Two Leishmania infantum Fluorescent Transgenic Clones.
by: Estefanía Calvo-Álvarez, et al.
Published: (2016-05-01)

Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf?
by: Rosa M. Reguera, et al.
Published: (2014-12-01)

In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against <i>Leishmania</i>
by: Estela Melcón-Fernández, et al.
Published: (2024-01-01)

Identification and characterization of the regions involved in the nuclear translocation of the heterodimeric leishmanial DNA topoisomerase IB.
by: Christopher F Prada, et al.
Published: (2013-01-01)

Antiparasitic effect of synthetic aromathecins on Leishmania infantum
by: Rosa M. Reguera, et al.
Published: (2019-11-01)

Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum
by: Camino Gutiérrez-Corbo, et al.
Published: (2019-12-01)

Axenic interspecies and intraclonal hybrid formation in Leishmania: Successful crossings between visceral and cutaneous strains
by: Camino Gutiérrez-Corbo, et al.
Published: (2022-02-01)

Resistance to Experimental Visceral Leishmaniasis in Mice Infected With Leishmania infantum Requires Batf3
by: Manuel Soto, et al.
Published: (2020-12-01)

Deletion study of DNA topoisomerase IB from Leishmania donovani: searching for a minimal functional heterodimer.
by: Rosario Díaz González, et al.
Published: (2007-01-01)

Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system.
by: Yaneth Osorio, et al.
Published: (2011-01-01)

Subcutaneous Immunization of <i>Leishmania HSP70-II</i> Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice
by: José Carlos Solana, et al.
Published: (2020-03-01)

Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery
by: Rafael Balaña-Fouce, et al.
Published: (2014-12-01)

Polyamine Metabolism for Drug Intervention in Trypanosomatids
by: Yolanda Pérez-Pertejo, et al.
Published: (2024-01-01)

Synthesis of Marine α-Methoxylated Fatty Acid Analogs that Effectively Inhibit the Topoisomerase IB from Leishmania donovani with a Mechanism Different from that of Camptothecin
by: Rosa M. Reguera, et al.
Published: (2013-09-01)

New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence.
by: Guilherme D Melo, et al.
Published: (2017-09-01)

Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo[S]
by: Mi-Jeong Lee, et al.
Published: (2019-04-01)

Editorial: New experimental and numerical insights on cardiovascular biomechanics through in-vivo and ex-vivo methods
by: Emanuele Vignali, et al.
Published: (2023-09-01)

Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies
by: Mudavath SL, et al.
Published: (2014-09-01)

Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study
by: Carvalho Edgar M, et al.
Published: (2004-11-01)

Mannose-Decorated Dendritic Polyglycerol Nanocarriers Drive Antiparasitic Drugs To <i>Leishmania infantum</i>-Infected Macrophages
by: Laura I. Vossen, et al.
Published: (2020-09-01)

Reproduction in Trypanosomatids: Past and Present
by: Camino Gutiérrez-Corbo, et al.
Published: (2021-05-01)

Potent In Vitro and Ex Vivo Anti-Gonococcal Activity of the RpoB Inhibitor Corallopyronin A
by: Jennifer L. Edwards, et al.
Published: (2022-10-01)

SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo
by: R.M. Dunham, et al.
Published: (2017-12-01)

Acylated and unacylated ghrelin directly regulate ß-3 stimulated lipid turnover in rodent subcutaneous and visceral adipose tissue ex vivo but not in vivo
by: Daniel T. Cervone, et al.
Published: (2019-01-01)

Epidemiology of visceral leishmaniasis
by: Ready PD
Published: (2014-05-01)

Congenital Visceral Leishmaniasis
by: Catharina C. Boehme, et al.
Published: (2006-02-01)

Treatment of visceral leishmaniasis
by: E M Moore, et al.
Published: (2010-01-01)

Leishmaniasis visceral canina
by: Bruno L. Trav
Published: (2000-01-01)

Immunobiology of visceral leishmaniasis
by: Susanne eNylén, et al.
Published: (2012-08-01)

Clinical Applications of In Vivo and Ex Vivo Confocal Microscopy
by: Stefania Guida, et al.
Published: (2021-02-01)

In Vivo and Ex Vivo Gene Electrotransfer in Ophthalmological Disorders
by: Roberta Fusco, et al.
Published: (2022-08-01)

Assays of CFTR Function In Vitro, Ex Vivo and In Vivo
by: Anabela Santo Ramalho, et al.
Published: (2022-01-01)

Ex Vivo and In Vivo Study of Some Isoquinoline Precursors
by: Miglena Milusheva, et al.
Published: (2022-06-01)

In Vitro, Ex Vivo, and In Vivo Models for the Study of Pemphigus
by: Roberta Lotti, et al.
Published: (2022-06-01)

Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches
by: Alessandro Fraldi, et al.
Published: (2018-11-01)

Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine.
by: Christine L Clouser, et al.
Published: (2011-01-01)